PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF METFORMIN AND GLIBENCLAMIDE

摘要

A method is provided for first line treatment of type 2 diabetes employing a combination of metformin and glyburide. A method for treating diabetes in drug naive human patients is also provided employing the above formulation to reduce insulin resistance and/or post-prandial glucose excursion and/or hemoglobin A1c, and/or increase post-prandial insulin, thereby treating the diabetes.